Skip Navigation
Print This Page
Share this page: More

Cerebrospinal Fluid (CSF) Repository

Currently there is no definitive test for Multiple Sclerosis (MS) and it may take several years to establish the diagnosis in some patients. Others may never have a definite diagnosis. It is generally agreed that if we were able to analyze the entire proteome and lipidome of the brain of MS patients, signature patterns could be established that would be diagnostic of the disease.

Since brain tissue is not accessible in live patients, but is bathed by the cerebrospinal fluid (CSF), we established a CSF bank of prospectively collected samples. This is the only such CSF bank in the country.

We have now applied highly sophisticated state-of-the-art instrumentation to analyze these samples with provocative results. Preliminary findings have been presented at national scientific meeting and further analysis is underway. Collaborators include Dr. Carlos Pardo. Dr Norman Haughey, a leading expert on lipidomic techniques, is using this fluid for studies of lipidic profiles and biomarker identification.


Related Links

Attacking Two Brain Disorders on Multiple Fronts
Uncover how Hopkins researchers are finding new treatments and diagnostic tools to treat multiple sclerosis and transverse myelitis.

Looking Forward

Read the latest issue of our newsletter

Looking Forward Fall 2014 cover

Previous Issues

Out-of-State and International Patients - Find Out More


© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.